Saxagliptin usually not associated with hypoglycemia or substantial changes in body weight
A few are explicitly banned
PlexusDx focuses on precision wellness by helping patients understand their unique metabolic and genetic profile before starting any GLP-1 therapy
NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells
GLP-1 medications have rapidly changed the conversation around diabetes, obesity, metabolic health, cardiovascular risk, and chronic disease management
Contamination Risks : If the vial is opened, bacteria or other contaminants can enter, especially if it is used past the recommended timeframe